Corvus Pharmaceuticals, Inc.
CRVS
$6.94
-$0.32-4.35%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 74.41M | 44.21M | 51.96M | 41.65M | 47.25M |
Total Receivables | 259.00K | 227.00K | 216.00K | 221.00K | 122.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 333.00K | 507.00K | 470.00K | 388.00K | 504.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 781.00K | 545.00K | 1.76M | 661.00K | 386.00K |
Total Current Assets | 75.78M | 45.49M | 54.41M | 42.92M | 48.26M |
|
|||||
Total Current Assets | 75.78M | 45.49M | 54.41M | 42.92M | 48.26M |
Net Property, Plant & Equipment | 1.26M | 1.26M | 1.33M | 455.00K | 770.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 626.00K | 629.00K | 632.00K | 252.00K | 129.00K |
Total Assets | 89.46M | 59.44M | 68.91M | 58.82M | 64.56M |
|
|||||
Total Accounts Payable | 3.14M | 1.31M | 2.58M | 1.87M | 1.21M |
Total Accrued Expenses | 4.67M | 3.58M | 3.44M | 3.81M | 4.07M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 355.00K | 319.00K | 185.00K | 354.00K | 700.00K |
Total Finance Division Other Current Liabilities | 346.00K | 4.08M | 29.20M | 40.37M | 7.35M |
Total Other Current Liabilities | 346.00K | 4.08M | 29.20M | 40.37M | 7.35M |
Total Current Liabilities | 8.51M | 9.28M | 35.40M | 46.41M | 13.34M |
|
|||||
Total Current Liabilities | 8.51M | 9.28M | 35.40M | 46.41M | 13.34M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 728.00K | 834.00K | 937.00K | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 9.23M | 10.11M | 36.34M | 46.41M | 13.34M |
|
|||||
Common Stock & APIC | 471.19M | 432.40M | 430.87M | 398.04M | 397.26M |
Retained Earnings | -389.82M | -381.82M | -397.01M | -384.90M | -344.68M |
Treasury Stock & Other | -1.15M | -1.25M | -1.29M | -738.00K | -1.36M |
Total Common Equity | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 80.23M | 49.33M | 32.57M | 12.41M | 51.23M |
|